Follow-up during four years after anti CD20 (Rituximab) trial in relapsed Follicular Lymphoma.

被引：0
|
作者：
Giraldo, P
Pelegrin, F
Palomera, L
Mayayo, P
Najera, MJ
Perdiguer, L
Puente, F
Rubio-Félix, D
机构：
[1] Miguel Servet Univ Hosp, Res Unit, Zaragoza, Spain
[2] SAHH, Zaragoza, Spain
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4933
引用
收藏
页码：302B / 303B
页数：2
相关论文
共 50 条
  • [1] Molecular response to anti CD20 (Rituximab) therapy in relapsed follicular lymphoma.
    Giraldo, P
    Pelegrin, F
    Palomera, L
    Recasens, V
    Najera, MJ
    Perdiguer, L
    Puente, F
    Rubio-Felix, D
    BLOOD, 2001, 98 (11) : 135A - 135A
  • [2] Evaluation of response to anti-CD20 (Rituximab) trial in relapsed follicular lymphoma after six years in follow-up.
    Rubio-Martinez, A
    Palomera, L
    Recasens, V
    Najera, MJ
    Perella, M
    Puente, F
    Perdiguer, L
    Rubio-Felix, D
    Mayayao, P
    Giraldo, P
    BLOOD, 2005, 106 (11) : 276B - 276B
  • [3] Relapsed follicular lymphoma.: Response to Fludarabine-Mitoxantrone regimen and monoclonal anti CD20 (Rituximab).
    Giraldo, P
    Pelegrín, F
    Palomera, L
    Recasens, V
    Nájera, MJ
    Puente, F
    Perdiguer, L
    Rubio-Félix, D
    BLOOD, 2000, 96 (11) : 730A - 730A
  • [4] Allogenic hematopoietic cell transplantation in relapsed follicular lymphoma: Unicentric analysis with 20 years of follow-up
    Peixeiro, R. Pinho
    Vaz, C. Pinho
    Quintela, M.
    Coelho, P.
    Leite, L.
    Branca, R.
    Roncon, S.
    Campos, A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 306 - 306
  • [5] Anti-CD20 (rituximab) in follicular lymphoma
    McLaughlin, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S51 - S51
  • [6] Rituxan™:: Anti CD20 monoclonal antibody for the treatment of lymphoma.
    Grillo-López, AJ
    White, CA
    Dallaire, BK
    Varns, C
    Shen, D
    McClure, A
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 746 - 746
  • [7] Loss of CD20 expression in relapsed lymphomas after rituximab therapy
    Haidar, JH
    Shamseddine, A
    Salem, Z
    Mrad, YA
    Nasr, MR
    Zaatari, G
    Bazarbachi, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (05) : 330 - 332
  • [8] 5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: A case report
    Tsutsumi Y.
    Ohigashi H.
    Ito S.
    Shiratori S.
    Teshima T.
    Journal of Medical Case Reports, 10 (1)
  • [9] MAHOGANY: A phase 3 trial of zanubrutinib plus anti-CD20 antibodies vs lenalidomide plus rituximab in patients with relapsed or refractory follicular or marginal zone lymphoma.
    Nastoupil, Loretta J.
    Song, Yuqin
    Sehn, Laurie Helen
    Sarkozy, Clementine
    Zinzani, Pier Luigi
    Silvestre, Antonio Salar
    Zhang, Jun
    Huang, Sha
    Wang, Julie
    Delarue, Richard
    Trotman, Judith
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Differential compartmental expression and distribution of CD20 and CD10 identifies subgroups of follicular lymphoma.
    Dojcinov, SD
    Boyde, AM
    Jasani, B
    O'Brien, CJ
    Attanoos, RL
    BLOOD, 2003, 102 (11) : 274B - 274B
12345